FNWFX
Price
$80.67
Change
-$1.85 (-2.24%)
Updated
Dec 18 closing price
NREMX
Price
$19.58
Change
-$0.32 (-1.61%)
Updated
Dec 18 closing price
Ad is loading...

FNWFX vs NREMX

Header iconFNWFX vs NREMX Comparison
Open Charts FNWFX vs NREMXBanner chart's image
American Funds New World F3
Price$80.67
Change-$1.85 (-2.24%)
VolumeN/A
CapitalizationN/A
Neuberger Berman Emerg Mkts Eq R6
Price$19.58
Change-$0.32 (-1.61%)
VolumeN/A
CapitalizationN/A
FNWFX vs NREMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNWFX vs. NREMX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNWFX is a Buy and NREMX is a Hold.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 64B vs. NREMX (194M). FNWFX pays higher dividends than NREMX: FNWFX (1.56) vs NREMX (1.38). FNWFX was incepted earlier than NREMX: FNWFX (8 years) vs NREMX (12 years). NREMX is a more actively managed with annual turnover of: 58.00 vs. FNWFX (32.00). NREMX has a lower initial minimum investment than FNWFX: NREMX (0) vs FNWFX (1000000). NREMX annual gain was more profitable for investors over the last year : 17.15 vs. FNWFX (12.00). FNWFX return over 5 years is better than : 16.03 vs. NREMX (1.56).
FNWFXNREMXFNWFX / NREMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years12 years-
Gain YTD10.02714.86267%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets64B194M32,990%
Annual Yield % from dividends1.561.38113%
Returns for 1 year12.0017.1570%
Returns for 3 years0.71-6.43-11%
Returns for 5 years16.031.561,030%
Returns for 10 yearsN/A34.96-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRC75.93-0.76
-0.99%
Brady Corp
GEN29.38-0.35
-1.18%
Gen Digital
SACH1.24-0.03
-2.36%
Sachem Capital Corp
NN17.55-0.45
-2.50%
NextNav
CANF1.42-0.09
-5.96%
Can-Fite BioPharma Ltd